Public Company News

Innovent Announces Inclusion in the China National Reimbursement Drug List (NRDL) of TYVYT in Two New Indications, Olverembatinib for the First Listing, BYVASDA, HALPRYZA and SULINNO in Multiple New Indications

ROCKVILLE, Md. and SUZHOU, China, Jan. 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...

2023-01-18 21:34 4944

Sims Limited Ranked 14th on Corporate Knights Global 100 List of the World's Most Sustainable Companies

NEW YORK, Jan. 18, 2023 /PRNewswire/ -- Sims Limited (ASX: SGM), a global leader in sustainability and an enabler of the circular economy, ranked 14th on the 2023 Global 100 List of most sustainable companies in the world by Corporate Knights. This is the company's ninth inclusion on the list. "...

2023-01-18 21:08 4435

CATL and NIO Enter Into Comprehensive Strategic Partnership

NINGDE, China, Jan. 18, 2023 /PRNewswire/ -- On January 17, CATL and NIO signed a five-year comprehensive strategic cooperation agreement in the city of Ningde, Southeast China's Fujian Province. Wei Zhu, executive president of passenger vehicle business unit of CATL, andAlan Zeng, senior vice pre...

2023-01-18 21:00 7366

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner SK bioscience has received expanded manufacturing and marketing...

2023-01-18 21:00 4328

RS celebrates strong first half revenue and profit performance

This outperformance is driven by the strength of RS employees, a purpose-led culture, and its differentiated proposition SINGAPORE, Jan. 18, 2023 /PRNewswire/ -- RS , a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of product and service ...

2023-01-18 17:18 3477

Invitation to Electrolux Q4 presentation

STOCKHOLM, Jan. 18, 2023 /PRNewswire/ -- Electrolux results for the fourth quarter of 2022 will be published onFebruary 2, 2023, at approximately 08.00 CET. A telephone conference will be held following the release of the results, starting at 09.00 CET.Jonas Samuelson, President and CEO and Ther...

2023-01-18 15:58 3388

Black Desert SEA Welcomes Charming Twin Class Maegu Along with a Special Gift

SEOUL, South Korea, Jan. 18, 2023 /PRNewswire/ -- Pearl Abyss announced today that the second twin class "Maegu" has finally arrived inBlack Desert SEA. First released onBlack Desert Mobile, she is now making a jump to unite with her younger twin sister. Adventurers can now experience both intrig...

2023-01-18 15:00 4632

Fosun Receives RMB12 Billion Syndicated Loan from 8 Banks to Jointly Promote Development of the Private Economy

HONG KONG, Jan. 18, 2023 /PRNewswire/ -- On 16 January 2023, Shanghai Fosun High Technology (Group) Co., Ltd. ("Fosun High Technology") and eight domestic banks held a syndicated loan signing ceremony at the Bund Finance Center, Shanghai. According to the agreement, Industrial and Commercial Bank ...

2023-01-18 12:01 5007

CATL and UL Solutions Join Forces to Advance Battery Safety and Performance

* CATL laboratory kicks off initiative to achieve UL Solutions Witness Test Data Program status for UL 9540A, allowing the company to offer comprehensive battery energy storage system testing. * The new collaboration sets the stage to help create safer, widespread deployment of key renewable,...

2023-01-18 11:14 5579

Infosys Ranked in the Top 3 IT Services Brands in the World; Among the Top 150 Most Valued Brands

Infosys brand value grows to US$13 billion according to Brand Finance Global 500 2023 Report DAVOS, Switzerland, Jan. 18, 2023 /PRNewswire/ -- Infosys  (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting, today announced tha...

2023-01-18 11:06 6667

Younger Twin Class Woosa Now Available in Black Desert Mobile

SEOUL, South Korea, Jan. 18, 2023 /PRNewswire/ -- Pearl Abyss announced today that the new "Woosa" class is now available inBlack Desert Mobile. Woosa was first released onBlack Desert PC and has now made her way to mobile as well. To celebrate her arrival, Adventurers can also expect to redeem l...

2023-01-18 10:00 4507

Telix Reports Fourth Quarter 2022 Financial Results

MELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ -- 18 January 2023. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended31 December 2022 (Q4 2022). All figures are in AUD$ ...

2023-01-18 08:50 4034

Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer

SUZHOU, China, Jan. 18, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that it will present t...

2023-01-18 08:00 3472

Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in China

Study findings suggest that EVER206 is well-tolerated with no new safety signals, supporting next-phase clinical development inChina SHANGHAI, Jan. 18, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest"), a biopharmaceutical company focused on the development, manufacturing and comm...

2023-01-18 07:30 4847

Abbisko Therapeutics Obtains Approval from The China NMPA to Conduct a Phase II Clinical Study of Pimicotinib (ABSK021) in cGVHD

SHANGHAI, Jan. 18, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that its CSF-1R inhibitor, pimicotinib (ABSK021), has been approved by the National Medical Products Administration ("NMPA") of the People's Republic ofChina for a phase II c...

2023-01-18 07:00 4616

Shutterstock Celebrates the Power of Storytelling at the 2023 Sundance Film Festival

NEW YORK, Jan. 18, 2023 /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK), the leading global creative platform for transformative brands and media and production companies, today announced its official sponsorship of the 2023 Sundance Film Festival as a Leadership Sponsor. Championing the work and...

2023-01-18 05:01 4625

Can-Am Factory Racers Make History Winning Sixth Dakar Rally

 Austin Jones Becomes Youngest Back-to-Back Dakar Champion in T3, Eryk Goczal Becomes Youngest Dakar Winner in T4  VALCOURT, QC, Jan. 17, 2023 /PRNewswire/ -- Can-Am, a brand of BRP (TSX: DOO) (NASDAQ: DOOO), has won its sixth straight Dakar Rally, winning both the T3 Lightweight Prototype class...

2023-01-17 20:55 5484

Accuray Announces First Patient Treatments in New Zealand With the CyberKnife® System, the World's Only Robotic Radiation Therapy Delivery Device

Auckland Radiation Oncology Selected the Latest-Generation CyberKnife S7™ System to Deliver Precise Treatments More Quickly, so Patients Can Rapidly Return to the Activities They Enjoy SUNNYVALE, Calif., Jan. 17, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Auckla...

2023-01-17 20:35 2910

Soltec Will Adopt Altair Technology to Accelerate and Advance Research and Development Efforts

Altair Units licensing system will provide access to full suite of Altair solutions TROY, Mich., Jan. 17, 2023 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI) announced that Soltec, a global solar equipment manufacturer based in Mur...

2023-01-17 20:00 3143

Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC

* World's first anti-PD-1 mAb for the first-line treatment of SCLC * Making a new record with the median OS of 15.8 months in an international, multi-center, phase 3 clinical trial * Granted orphan drug designations by the FDA and the EC, paving the way for international commercialization SH...

2023-01-17 19:42 4419
1 ... 685686687688689690691 ... 903